Man K S Lee1,2, Xiao-Lei Moore1, Yi Fu1, Annas Al-Sharea1,2, Dragana Dragoljevic1,2, Manuel A Fernandez-Rojo3, Robert Parton4, Dmitri Sviridov1, Andrew J Murphy1,5, Jaye P F Chin-Dusting1,2. 1. Baker IDI Heart and Diabetes Institute, Melbourne, Australia. 2. Department of Medicine (Alfred), Monash University, Melbourne, Australia. 3. Department of Cell and Molecular Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia. 4. Institute for Molecular Bioscience and Centre for Microscopy and Microanalysis, The University of Queensland, Brisbane, Australia. 5. Department of Immunology, Monash University, Melbourne, Australia.
Abstract
BACKGROUND AND PURPOSE: Monocyte-derived macrophages are critical in the development of atherosclerosis and can adopt a wide range of functional phenotypes depending on their surrounding milieu. High-density lipoproteins (HDLs) have many cardio-protective properties including potent anti-inflammatory effects. We investigated the effects of HDL on human macrophage phenotype and the mechanisms by which these occur. EXPERIMENTAL APPROACH: Human blood monocytes were differentiated into macrophages in the presence or absence of HDL and were then induced to either an inflammatory macrophage (M1) or anti-inflammatory macrophage (M2) phenotype using LPS and IFN-γ or IL-4, respectively. KEY RESULTS: HDL inhibited the induction of macrophages to an M1-phenotype, as evidenced by a decrease in the expression of M1-specific cell surface markers CD192 and CD64, as well as M1-associated inflammatory genes TNF-α, IL-6 and MCP-1 (CCL2). HDL also inhibited M1 function by reducing the production of ROS. In contrast, HDL had no effect on macrophage induction to the M2-phenotype. Similarly, methyl-β-cyclodextrin, a non-specific cholesterol acceptor also suppressed the induction of M1 suggesting that cholesterol efflux is important in this process. Furthermore, HDL decreased membrane caveolin-1 in M1 macrophages. We confirmed that caveolin-1 is required for HDL to inhibit M1 induction as bone marrow-derived macrophages from caveolin-1 knockout mice continued to polarize into M1-phenotype despite the presence of HDL. Moreover, HDL decreased ERK1/2 and STAT3 phosphorylation in M1 macrophages. CONCLUSIONS AND IMPLICATIONS: We concluded that HDL reduces the induction of macrophages to the inflammatory M1-phenotype via redistribution of caveolin-1, preventing the activation of ERK1/2 and STAT3.
BACKGROUND AND PURPOSE: Monocyte-derived macrophages are critical in the development of atherosclerosis and can adopt a wide range of functional phenotypes depending on their surrounding milieu. High-density lipoproteins (HDLs) have many cardio-protective properties including potent anti-inflammatory effects. We investigated the effects of HDL on human macrophage phenotype and the mechanisms by which these occur. EXPERIMENTAL APPROACH: Human blood monocytes were differentiated into macrophages in the presence or absence of HDL and were then induced to either an inflammatory macrophage (M1) or anti-inflammatory macrophage (M2) phenotype using LPS and IFN-γ or IL-4, respectively. KEY RESULTS: HDL inhibited the induction of macrophages to an M1-phenotype, as evidenced by a decrease in the expression of M1-specific cell surface markers CD192 and CD64, as well as M1-associated inflammatory genes TNF-α, IL-6 and MCP-1 (CCL2). HDL also inhibited M1 function by reducing the production of ROS. In contrast, HDL had no effect on macrophage induction to the M2-phenotype. Similarly, methyl-β-cyclodextrin, a non-specific cholesterol acceptor also suppressed the induction of M1 suggesting that cholesterol efflux is important in this process. Furthermore, HDL decreased membrane caveolin-1 in M1 macrophages. We confirmed that caveolin-1 is required for HDL to inhibit M1 induction as bone marrow-derived macrophages from caveolin-1 knockout mice continued to polarize into M1-phenotype despite the presence of HDL. Moreover, HDL decreased ERK1/2 and STAT3 phosphorylation in M1 macrophages. CONCLUSIONS AND IMPLICATIONS: We concluded that HDL reduces the induction of macrophages to the inflammatory M1-phenotype via redistribution of caveolin-1, preventing the activation of ERK1/2 and STAT3.
Authors: Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar Journal: Br J Pharmacol Date: 2013-12 Impact factor: 8.739
Authors: Alex W Cohen; David S Park; Scott E Woodman; Terrence M Williams; Madhulika Chandra; Jamshid Shirani; Andrea Pereira de Souza; Richard N Kitsis; Robert G Russell; Louis M Weiss; Baiyu Tang; Linda A Jelicks; Stephen M Factor; Vitaliy Shtutin; Herbert B Tanowitz; Michael P Lisanti Journal: Am J Physiol Cell Physiol Date: 2002-10-09 Impact factor: 4.249
Authors: Dominic De Nardo; Larisa I Labzin; Hajime Kono; Reiko Seki; Susanne V Schmidt; Marc Beyer; Dakang Xu; Sebastian Zimmer; Catharina Lahrmann; Frank A Schildberg; Johanna Vogelhuber; Michael Kraut; Thomas Ulas; Anja Kerksiek; Wolfgang Krebs; Niklas Bode; Alena Grebe; Michael L Fitzgerald; Nicholas J Hernandez; Bryan R G Williams; Percy Knolle; Manfred Kneilling; Martin Röcken; Dieter Lütjohann; Samuel D Wright; Joachim L Schultze; Eicke Latz Journal: Nat Immunol Date: 2013-12-08 Impact factor: 25.606
Authors: Vlasta Demeckova; Dagmar Mudronova; Sona Gancarcikova; Peter Kubatka; Karol Kajo; Monika Kassayova; Bianka Bojkova; Marian Adamkov; Peter Solár Journal: Int J Mol Sci Date: 2022-06-07 Impact factor: 6.208
Authors: Man K S Lee; Xiao-Lei Moore; Yi Fu; Annas Al-Sharea; Dragana Dragoljevic; Manuel A Fernandez-Rojo; Robert Parton; Dmitri Sviridov; Andrew J Murphy; Jaye P F Chin-Dusting Journal: Br J Pharmacol Date: 2015-10-30 Impact factor: 8.739
Authors: Yuri V Bobryshev; Ekaterina A Ivanova; Dimitry A Chistiakov; Nikita G Nikiforov; Alexander N Orekhov Journal: Biomed Res Int Date: 2016-07-17 Impact factor: 3.411